These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3102176)

  • 1. Complement pathway activity in the opsonization of mutant strains of Salmonella typhimurium.
    Shaio MF; Rowland H
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 May; 19(2):137-52. PubMed ID: 3102176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium.
    Shaio MF; Rowland H
    Infect Immun; 1985 Sep; 49(3):647-53. PubMed ID: 3897060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of EGTA on phagocytosis of Salmonella typhimurium by human neutrophils.
    Shaio MF; Rowland H
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 May; 19(2):153-9. PubMed ID: 3102177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
    Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP
    Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ; Grossman N; Leive L
    J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway.
    Vandenbosch JL; Rabert DK; Jones GW
    Infect Immun; 1987 Nov; 55(11):2645-52. PubMed ID: 3312005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.
    Nishikawa F; Yoshikawa S; Harada H; Kita M; Kita E
    Immunology; 1998 Dec; 95(4):640-7. PubMed ID: 9893057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative pathway of complement by antiserum to factor B.
    Wilson MR; Arroyave CM; Tan EM
    J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.
    Tomás JM; Ciurana B; Benedí VJ; Juarez A
    J Gen Microbiol; 1988 Apr; 134(4):1009-16. PubMed ID: 3053980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement.
    Hoffmann EM; Houle JJ
    Vet Immunol Immunopathol; 1983 Nov; 5(1):65-76. PubMed ID: 6419447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of bactericidal action of normal human serum against Salmonella rods.
    Mokracka-Latajka G; Jankowski S; Grzybek-Hryncewicz K; Krzyzanowska B
    Acta Microbiol Pol; 1996; 45(2):169-80. PubMed ID: 8997694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.